SMi’s 8th Annual Pharmaceutical Microbiology
Copthorne Tara Hotel, London, UK (January 21 - 22, 2019)
SMi’s 8th Annual Pharmaceutical Microbiology
Addressing the key trends, challenges and strategies in contamination control
Conference: 21 & 22 January 2019
Workshops: 23 January 2019
The pharmaceutical microbiology industry has seen many changes during the progression into the 21st century. With advances in rapid microbiological methods, revisions being made to regulations in the industry, enhanced knowledge of the human microbiome, and novel testing methods, this industry is ever expanding. In fact, the value of the rapid microbiology testing market is expected to reach USD 6.2 Billion by 2022, expanding at a CAGR of 7.3% from 2016 to 2022. This is the 8th year of a conference which is continually run by SMi and which has been very successful over the past few years.
Developing on last years’ success, Pharmaceutical Microbiology UK 2019 will bring together industry experts to discuss and analyse the latest advancement and challenges within pharmaceutical microbiology. Discover how you can keep up with regulatory changes and maintain the utmost efficiency during production and testing.
Event Hashtag: #PharmaMicro
At the 8th Annual Pharmaceutical Microbiology Conference, you will gain insight into:
- Challenges in development of a contamination control strategy for different product types
- A series of learning experiences within contamination from Boehringer Ingelheim
- The use of vaporized hydrogen peroxide bio-decontamination technology in microbiology contamination control
- Case studies in deinococcus and fungal and bacterial spores in cleanrooms
- Influence of temperature of incubation on results of microbiological environmental monitoring
- Risk mitigation strategies for animal-derived raw materials
FEATURED SPEAKERS INCLUDE:
- Alexander Stoll, VP Competence Center Microbiology & Aseptic Technique Quality Management, Fresenius Kabi
- Di Morris, Senior Manager, Team Leader, Vaccines Quality Audit, GSK
- Marine Marius, Scientist, Analytical Research & Development Europe, Sanofi Pasteur
- Philippe Dutot, Sterility Assurance Specialist, Novo Nordisk
- Renate Rosengarten, Professor and Chair of Bacteriology and Hygiene, University of Veterinary Medicine Vienna
- Thierry Bonnevay, Microbiology Platform Head, Analytical Research and Development, Sanofi Pasteur
- Tim Eaton, Sterile Manufacturing Specialist, AstraZeneca
KEY TOPICS FOR 2019 INCLUDE:
- Rapid Microbial Methods
- Revision of Annex 1 and impact on pharmaceutical microbiology
- Contamination control strategies and case studies
- Mycoplasma detection, prevention and control
- Future of endotoxin testing in pharmaceutical industries
- Strengths and weaknesses of vaporized Hydrogen peroxide as a bio-contamination control agent
- Mold contamination control
- Influence of temperature of incubation on results of microbiological environmental monitoring
View the full agenda: www.pharma-microbiology.com/gate2biotech
WHO SHOULD ATTEND
Senior Microbiologist, Lead Scientist, Laboratory Manager, QA Specialist Drug Substance External Manufacturer, Business Development Manager – Testing, Pharmaceutical Microbiology Consultant, Higher Pharmacopoeia Scientist, Analytical Standards Specialist
